These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 7683221)

  • 1. Hypercoagulability during induction therapy of acute lymphoblastic leukemia is of scarce clinical relevance. Gruppo Italiano Malattie Ematologiche Maligne dell' Adulto.
    de Stefano V; Gugliotta L; Mazzucconi MG; Leone G; Mandelli F
    Blood; 1993 May; 81(9):2468-9. PubMed ID: 7683221
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of dose-reduced Medac L-asparaginase on coagulation in trial ALL-BFM 2000.
    Attarbaschi A; Mann G; Kronberger M; Witt V; Gadner H; Dworzak M
    Klin Padiatr; 2003; 215(6):321-6. PubMed ID: 14677096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in hypercoagulability by asparaginase: a randomized study between two asparaginases.
    Appel IM; Hop WC; Pieters R
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):139-46. PubMed ID: 16479196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of acute lymphoblastic leukemia French protocol Fralle 83-87.
    Schaison G; Sommelet D; Bancillon A; Perel Y; Leblanc T; Bergeron C; Lejars O; Baruchel A; Lepage E; Leverger G
    Leukemia; 1992; 6 Suppl 2():148-52. PubMed ID: 1578919
    [No Abstract]   [Full Text] [Related]  

  • 5. GIMEMA ALL 0288: a multicentric study on adult acute lymphoblastic leukemia. Preliminary results.
    Mandelli F; Annino L; Vegna ML; Camera A; Ciolli S; Deplano W; Fabiano F; Ferrara F; Ladogana S; Muti G
    Leukemia; 1992; 6 Suppl 2():182-5. PubMed ID: 1578928
    [No Abstract]   [Full Text] [Related]  

  • 6. Minimal residual disease-guided therapy in childhood acute lymphoblastic leukemia.
    Campana D; Pui CH
    Blood; 2017 Apr; 129(14):1913-1918. PubMed ID: 28167658
    [No Abstract]   [Full Text] [Related]  

  • 7. Thromboembolic events in children with acute lymphoblastic leukemia (BFM protocols): prednisone versus dexamethasone administration.
    Nowak-Göttl U; Ahlke E; Fleischhack G; Schwabe D; Schobess R; Schumann C; Junker R
    Blood; 2003 Apr; 101(7):2529-33. PubMed ID: 12517808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intensive therapy for adult acute lymphoblastic leukemia.
    Berman E; Weiss M; Kempin S; Gee T; Bertino J; Clarkson B
    Semin Hematol; 1991 Jul; 28(3 Suppl 4):72-5. PubMed ID: 1780756
    [No Abstract]   [Full Text] [Related]  

  • 9. [Investigations in the use of mogramostime (GM-CSF) in patients with acute leukemia].
    Paśnicki M
    Wiad Lek; 1995; 48(1-12):194-7. PubMed ID: 9638239
    [No Abstract]   [Full Text] [Related]  

  • 10. Markers of in vivo activation of coagulation. Interrelationships change with intensity of oral anticoagulation.
    Solymoss S; Bovill EG
    Am J Clin Pathol; 1996 Mar; 105(3):293-7. PubMed ID: 8602609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase.
    Oner AF; Gürgey A; Kirazli S; Okur H; Tunç B
    Leuk Lymphoma; 1999 Apr; 33(3-4):361-4. PubMed ID: 10221516
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of hypercoagulation by antithrombin substitution in E. coli L-asparaginase-treated children.
    Nowak-Göttl U; Kuhn N; Wolff JE; Boos J; Kehrel B; Rath B; Jürgens H
    Eur J Haematol; 1996; 56(1-2):35-8. PubMed ID: 8599991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in blood coagulation in treatment with ALL-BFM-90 and NHL-BFM-90 protocols].
    Sutor AH; Niemeyer C; Sauter S; Witt I; Kaufmehl K; Rombach A; Brandis M; Riehm H
    Klin Padiatr; 1992; 204(4):264-73. PubMed ID: 1518263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follow-up of the first two successive German multicentre trials for adult ALL (01/81 and 02/84). German Adult ALL Study Group.
    Hoelzer D; Thiel E; Ludwig WD; Löffler H; Büchner T; Freund M; Heil G; Hiddemann W; Maschmeyer G; Völkers B
    Leukemia; 1993 Aug; 7 Suppl 2():S130-4. PubMed ID: 8361217
    [No Abstract]   [Full Text] [Related]  

  • 15. [The programmed therapy of acute lymphoblastic leukemia in adults].
    Isaev VG; Savchenko VG; Kucher RA; Abakumov EM; Parovichnikova EN
    Ter Arkh; 1992; 64(8):82-7. PubMed ID: 1440405
    [No Abstract]   [Full Text] [Related]  

  • 16. Randomized post-induction and delayed intensification therapy in high-risk pediatric acute lymphoblastic leukemia: long-term results of the international AIEOP-BFM ALL 2000 trial.
    Attarbaschi A; Mann G; Zimmermann M; Bader P; Barisone E; Basso G; Biondi A; Cario G; Cazzaniga G; Colombini A; Flotho C; Kuhlen M; Lang P; Lauten M; Linderkamp C; Locatelli F; Lo Nigro L; Möricke A; Niggli F; Panzer-Grümayer R; Parasole R; Peters C; Caterina Putti M; Rizzari C; Suttorp M; Valsecchi MG; Conter V; Schrappe M;
    Leukemia; 2020 Jun; 34(6):1694-1700. PubMed ID: 31806872
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current status of the treatment of acute lymphocytic leukemia in the adult].
    Shi YD; Zhang ZN
    Zhonghua Nei Ke Za Zhi; 1989 Aug; 28(8):499-502. PubMed ID: 2689108
    [No Abstract]   [Full Text] [Related]  

  • 18. Effectiveness of rubidomycin in induction therapy with vincristine, prednisone, and L-asparaginase for standard risk childhood acute lymphocytic leukemia: results of a Dutch phase III study (ALL V). A report on behalf of the Dutch Childhood Leukemia Study Group (DCLSG).
    van der Does-van den Berg A; van Wering ER; Suciu S; Solbu G; van 't Veer MB; Rammeloo JA; de Koning J; van Zanen GE
    Am J Pediatr Hematol Oncol; 1989; 11(2):125-33. PubMed ID: 2665546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of IKZF1 deletions in association with vincristine-dexamethasone pulses during maintenance treatment of childhood acute lymphoblastic leukemia on trial ALL-BFM 95.
    Hinze L; Möricke A; Zimmermann M; Junk S; Cario G; Dagdan E; Kratz CP; Conter V; Schrappe M; Stanulla M
    Leukemia; 2017 Aug; 31(8):1840-1842. PubMed ID: 28529312
    [No Abstract]   [Full Text] [Related]  

  • 20. A randomized trial of induction therapy (daunorubicin, vincristine, prednisone versus daunorubicin, vincristine, prednisone, cytarabine and 6-thioguanine) in adult acute lymphoblastic leukemia with long-term follow-up: an Eastern Cooperative Oncology Group Study (E3486).
    Wiernik PH; Cassileth PA; Leong T; Hoagland HC; Bennett JM; Paietta E; Oken MM;
    Leuk Lymphoma; 2003 Sep; 44(9):1515-21. PubMed ID: 14565653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.